Clinical Trial

Human ADME Study of [14C]-AZD1390

Name: Human ADME Study of [14C]-AZD1390 — clinical trial record (NCT07643870)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a Phase I, multicentre, single-dose, open-label study to assess the absorption, distribution, metabolism, and excretion of \[14C\]-AZD1390.

Trial Details

NCT Number	NCT07643870
Lead Sponsor	AstraZeneca
Conditions	Advanced Solid Malignancies
Enrollment	8 participants
Start Date	2026-06-30
Primary Completion	2028-04-12 (estimated)
Study Completion	2028-04-12 (estimated)
Updated on ClinicalTrials.gov	2026-06-12